Abstracts Archive - Page 2585 of 2607 - ACR Meeting Abstracts

Abstract Number: 282 • 2012 ACR/ARHP Annual Meeting
Clinical and Laboratory Features Distinguishing Juvenile Polymyositis and Muscular Dystrophy in Children
Gulnara Mamyrova¹, James D. Katz¹, Robert V. Jones², Peter A. Lachenbruch³, Mona Shah³, Olcay Y. Jones¹, Anupam Chahal¹, Seema Agrawal¹, Frederick W. Miller³, Lisa G. Rider³ and the Childhood Myositis Heterogeneity Group⁴, ¹Rheumatology, George Washington University, Washington, DC, ²Pathology, George Washington University, Washington, DC, ³Environmental Autoimmunity Group, NIEHS, NIH, Bethesda, MD, ⁴Niehs, NIH, Bethesda, MD
Background/Purpose: We examined demographic, clinical and laboratory features of juvenile polymyositis (JPM) and muscular dystrophy in children to improve classification of these two conditions. Methods:…
Abstract Number: 283 • 2012 ACR/ARHP Annual Meeting
Hospitalizations for Patients with Chilhood-Onset Systemic Lupus Erythematosus in the Pediatric Health Information System Databse
Aimee O. Hersh¹, Charlie Casper¹, Tellen D. Bennett¹, Susan L. Bratton¹, John F. Bohnsack² and Rajendu Srivastava¹, ¹Pediatrics, University of Utah, Salt Lake City, UT, ²Dept of Pediatriacs, University of Utah, Salt Lake City, UT
Background/Purpose: To describe patient demographics, admission characteristics and clinical care for hospitalized patients with childhood-onset systemic lupus erythematous (SLE). Methods: Retrospective cohort study of the…
Abstract Number: 284 • 2012 ACR/ARHP Annual Meeting
Treatment and Outcome of ANCA-Associated Vasculitis in Children: A Pilot Study
Marinka Twilt¹, Audrey Bell-Peter¹, Ronald Laxer², Christian Pagnoux³, Diane Hebert⁴, Elizabeth Harvey⁴, Shehla Sheikh² and Susanne M. Benseler², ¹Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ²Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ³Rheumatology, Mount Sinai Hospital, Toronto, Canada, Toronto, ON, Canada, ⁴Nephrology, The Hospital for Sick Children, Toronto, ON, Canada
Background/Purpose: Childhood ANCA vasculitides are rare, yet organ- or even life-threatening systemic vasculitides. Children most frequently present with rapidly evolving, severe disease such as pulmonary-renal…
Abstract Number: 285 • 2012 ACR/ARHP Annual Meeting
Rituximab for Severe Disease Flares in Childhood ANCA Vasculitides
Marinka Twilt¹, Rayfel Schneider², Audrey Bell-Peter¹, Sharon Dell³ and Susanne M. Benseler⁴, ¹Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ²Pediatric Rheumatology Collaborative Study Group (PRCSG), Cincinnati, OH, Canada, ³Respiratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada, ⁴Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada
Background/Purpose: Children with ANCA vasculitides frequently present with life-threatening organ manifestations including alveolar hemorrhage, critical subglottic stenosis and renal failure due to rapidly progressive glomerulonephritis…
Abstract Number: 286 • 2012 ACR/ARHP Annual Meeting
The Association of N-Methyl-D-Aspartate Receptor Antibodies and Neurocognitive Dysfunction in Pediatric Lupus Patients and in the Offspring of Adult Patients with Lupus
Natasha M. Ruth¹, Mary C. Kral², Stephanie Slan³, Tamara K. Nowling⁴, Murray H. Passo¹ and Gary S. Gilkeson³, ¹Pediatric Rheumatology, Medical University of South Carolina, Charleston, SC, ²Genetics and Developmental Pediatrics, MUSC, Charleston, SC, ³Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC, ⁴Medical University of South Carolina, Charleston, SC
Background/Purpose: Approximately 1/5 of all systemic lupus erythematosus (SLE) starts in childhood and central nervous system (CNS) dysfunction is more common in childhood-onset SLE. CNS…
Abstract Number: 287 • 2012 ACR/ARHP Annual Meeting
Variation in Healthcare Utilization by Region and Number of Rheumatologists Per State Among Pediatric Medicaid Patients with Lupus Nephritis Prior to End-Stage Renal Disease in the United States, 2000-2004
Linda T. Hiraki¹, Candace H. Feldman², Graciela S. Alarcon³, Jun Liu⁴, Michael A. Fischer⁵, Wolfgang C. Winkelmayer⁶ and Karen H. Costenbader⁷, ¹Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard School of Public Health, Boston, MA, ²Rheumatology, Brigham and Women's Hospital, Boston, MA, ³Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, ⁴Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Boston, MA, ⁵Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, ⁶Division of Nephrology, Stanford University School of Medicine, Stanford, CA, ⁷Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Unequal healthcare access and utilization may contribute to the striking sociodemographic disparities seen in outcomes for children with lupus nephritis. Medicaid is the U.S.…
Abstract Number: 288 • 2012 ACR/ARHP Annual Meeting
Validation of Promis Modules for Use in Childhood-Onset Lupus
Alexandria J. Greenler¹, Laura E. Schanberg², Michael P. Flannery¹, Shannen Nelson³, Janet Wootton⁴, Esi M. Morgan DeWitt³ and Hermine Brunner⁵, ¹Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ²Pediatrics, Duke University Medical Center, Durham, NC, ³Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁴Pediatric Rheumatology, Duke University Medical Center, Durham, NC, ⁵Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Background/Purpose: The impact of childhood-onset lupus (cSLE) and its treatment on quality of life (QoL) has not been systematically established. The Patient Reported Outcomes Measurement…
Abstract Number: 247 • 2012 ACR/ARHP Annual Meeting
Meager Depression Screening and Mental Health Referral Rates for Patients with Arthritis in a National Sample
Mary Margaretten¹, Patricia P. Katz², Laura Trupin², Gabriela Schmajuk³, Jennifer Barton⁴, Jinoos Yazdany⁵ and Edward H. Yelin⁶, ¹Rheumatology, University of California, San Francisco, San Francisco, CA, ²Medicine, UCSF, San Francisco, CA, ³Rheumatology, UCSF / San Francisco VA Medical Center, San Francisco, CA, ⁴Medicine, University of California, San Francisco, San Francisco, CA, ⁵Rheumatology, UCSF, San Francisco, CA, ⁶Arthritis Research Group, UCSF, San Francisco, CA
Background/Purpose: Depression in patients with arthritis is common and leads to poor health outcomes. While it has been shown that rheumatologists rarely communicate about depression…
Abstract Number: 248 • 2012 ACR/ARHP Annual Meeting
Synovial Fluid Leptin Level Is Associated with Residual Pain and Functional Disability One Year After Total Joint Arthroplasty
Anne Lübbeke¹, Gabor J. Puskas¹, Axel Finckh², Domizio Suva¹, Sylvette Bas³, Cem Gabay³, Daniel Fritschy¹ and Pierre Hoffmeyer¹, ¹Orthopaedic Surgery, Geneva University Hospitals, Geneva, Switzerland, ²Rheumatology, Geneva University Hospitals, Geneva 14, Switzerland, ³Rheumatology, Geneva University Hospitals, Geneva, Switzerland
Background/Purpose: A sizeable number of patients continue to suffer from pain, functional disability and reduced quality of life after total joint arthroplasty (TJA). The etiology…
Abstract Number: 249 • 2012 ACR/ARHP Annual Meeting
Medial Subchondral Bone Marrow Lesions Increase the Odds of Knee Joint Replacement – Data From the Osteoarthritis Initative
Frank Roemer¹, C. Kent Kwoh², David Hunter³, Michael J. Hannon⁴, Robert M. Boudreau⁵, Felix Eckstein⁶, Zhijie Wang⁴, Markus R. John⁷ and Ali Guermazi⁸, ¹Klinikum Augsburg, Augsburg, Germany, ²School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, ³Royal North Shore Hospital, St. Leonards, Australia, ⁴Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, ⁵Epidemiology, University of Pittsburgh, Pittsburgh, PA, ⁶Anatomy & Musculoskeletal Research, Paracelsus Medical University, Salzburg, Austria, ⁷Novartis Pharma AG, Basel, Switzerland, ⁸Boston University, Boston, MA
Background/Purpose: Knee joint replacement (KR) is a cost-effective procedure with good long-term outcomes. However, there is no clear consensus on indications for KR. Subchondral bone…
Abstract Number: 250 • 2012 ACR/ARHP Annual Meeting
Incident and Worsening Cartilage Damage in the Lateral Compartment and Multiple Subregions Worsening in the Medial Compartment Increase the Risk for Knee Replacement – Data From the Osteoarthritis Initiative
Frank Roemer¹, C. Kent Kwoh², Michael J. Hannon³, Robert M. Boudreau⁴, Felix Eckstein⁵, David J. Hunter⁶, Zhijie Wang³, Markus R. John⁷ and Ali Guermazi⁸, ¹Klinikum Augsburg, Augsburg, Germany, ²School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, ³Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, ⁴Epidemiology, University of Pittsburgh, Pittsburgh, PA, ⁵Anatomy & Musculoskeletal Research, Paracelsus Medical University, Salzburg, Austria, ⁶Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, ⁷Novartis Pharma AG, Basel, Switzerland, ⁸Boston University, Boston, MA
Background/Purpose: Knee joint replacement (KR) is a cost-effective procedure with good long-term outcomes. However, at present there is no clear consensus on indications for KR.…
Abstract Number: 251 • 2012 ACR/ARHP Annual Meeting
Smaller Baseline and Follow-up Quadriceps Muscle Cross-Sectional Area Increases the Odds of Knee Replacement in Knee Osteoarthritis
Serter Gumus¹, Michael J. Hannon², Diana Kaya¹, C. Kent Kwoh³ and Kyongtae Ty Bae¹, ¹Radiology, University of Pittsburgh, Pittsburgh, PA, ²Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, ³School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA
Background/Purpose: Knee osteoarthritis (OA) is one of the major causes of disability among elderly. Knee replacement (KR) is the final effective treatment of OA after…
Abstract Number: 252 • 2012 ACR/ARHP Annual Meeting
Presence of Severe Medial Mensical Pathology Increases the Odds for Knee Replacement: Data From the Osteoarthritis Initiative
Frank Roemer¹, C. Kent Kwoh², David J. Hunter³, Robert M. Boudreau⁴, Michael J. Hannon⁵, Markus R. John⁶, Felix Eckstein⁷, Michel Crema⁸, Zhijie Wang⁵ and Ali Guermazi⁸, ¹Klinikum Augsburg, Augsburg, Germany, ²School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, ³Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, ⁴Epidemiology, University of Pittsburgh, Pittsburgh, PA, ⁵Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, ⁶Novartis Pharma AG, Basel, Switzerland, ⁷Anatomy & Musculoskeletal Research, Paracelsus Medical University, Salzburg, Austria, ⁸Boston University, Boston, MA
Background/Purpose: Knee joint replacement (KR) is a cost-effective procedure with good long-term outcome. However, at present there is no clear consensus on indications for KR.…
Abstract Number: 253 • 2012 ACR/ARHP Annual Meeting
Incidence of Osteoarthritis-Related Knee and Hip Joint Surgery in Southern Sweden
Aleksandra Turkiewicz¹, Ingemar F. Petersson², Leif E. Dahlberg¹ and Martin Englund¹, ¹Department of Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden, ²Lund University, Lund, Sweden
Background/Purpose: To estimate the incidence and age and sex patterns of subjects having had osteoarthritis (OA)-related surgical treatment. Methods: The Skåne Health Care Register (SHCR)…
Abstract Number: 254 • 2012 ACR/ARHP Annual Meeting
Effects of Strontium Ranelate On Knee Osteoarthritis Pain: A Responder Analysis
JY. Reginster¹, Roland Chapurlat², N. Bellamy³, E. Czerwinski⁴, JP Devogelaer⁵, Lyn March⁶, K. Pavelka⁷ and Cyrus Cooper⁸, ¹Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium, ²Hôpital Edouard Herriot, Lyon, France, ³CONROD. The University of Queensland, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia, ⁴Krakow Medical Centre, Kraków, Poland, ⁵Service de Rhumatologie, Cliniques Universitaires St. Luc, Brussels, Belgium, ⁶University of Sydney, Institute of Bone and Joint Research, Royal North Shore Hospital, St Leonards - Sydney, Australia, ⁷Department of Clinical and Experimental Rheumatology, Charles University, Prague, Czech Republic, ⁸NDORMS; MRC Lifecourse Epidemiology Unit, University of Oxford; Southampton General Hospital, Southampton, United Kingdom
Background/Purpose: In a large, randomised, placebo-controlled, double-blind phase-III 3-year study (SEKOIA), strontium ranelate 2g/day (SrRan) has demonstrated structure-modifying activity associated with statistically significant symptomatic improvement…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].